viernes, 18 de junio de 2021

GSK Sotrovimab Fact Sheet for HCP 05262021-FDA Authorizes Sotrovimab Monoclonal Antibody for Treatment of COVID-19

GSK Sotrovimab Fact Sheet for HCP 05262021

No hay comentarios:

Publicar un comentario